Pear announces inclusion of reSET, reSET-O on Florida Medicaid PDL

Pear Therapeutics announced the inclusion of its PDTs reSET and reSET-O on the January 2023 Florida Medicaid Preferred Drug List, PDL. reSET and reSET-O, the only FDA-authorized PDTs for the treatment of substance use disorder and opioid use disorder, respectively, have been added to the Florida Medicaid PDL, effective January 1, 2023. "Pear applauds Florida leadership for bringing reSET and reSET-O to its millions of Medicaid members in its persistent efforts to tackle the addiction crisis and bring innovative treatment options to those seeking recovery," said Julia Strandberg, Chief Commercial Officer of Pear Therapeutics. "The unmet need in addiction across the U.S. is enormous, and Florida represents an important step in how we are helping more and more patients by working with states to provide covered access to our products."